Page last updated: 2024-12-08

eicosa-5,11,14-trienoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

eicosa-5,11,14-trienoic acid: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6440225
SCHEMBL ID542240
SCHEMBL ID542242
MeSH IDM0132343

Synonyms (7)

Synonym
(5e,11e,14e)-icosa-5,11,14-trienoic acid
eicosa-5,11,14-trienoic acid
5,11,14-eicosatrienoic acid
icosa-5,11,14-trienoic acid
15541-36-3
SCHEMBL542240
SCHEMBL542242
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.90)18.7374
1990's4 (13.79)18.2507
2000's10 (34.48)29.6817
2010's10 (34.48)24.3611
2020's3 (10.34)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]